Latest News and Press Releases
Want to stay updated on the latest news?
-
MOUNTAIN VIEW, Calif., July 14, 2025 (GLOBE NEWSWIRE) -- Borvo Medical, a neurosurgical medtech startup and a portfolio company of NeuroTechnology Investors (NTI), today announced a 100% success...
-
Burlingame, CA, July 10, 2025 (GLOBE NEWSWIRE) -- The global Brain Monitoring Market is estimated to be valued at USD 4,154.7 Mn in 2025 and is expected to reach USD 6,715.3 Mn in 2032, exhibiting a...
-
LOS GATOS, calif., July 10, 2025 (GLOBE NEWSWIRE) -- Radical Catheter Technologies™, a pioneering medical device company and a NeuroTechnology Investors (NTI) portfolio company focused on advancing...
-
FDA has cleared the new Magstim Rapid TMS system for research and clinical applications, now with FDA clearance in the U.S. for the treatment of pain.
-
PathMaker Announces Publication of First Study Demonstrating Increased Survival in an ALS Mouse Model After Treatment With Non-Invasive Neuromodulation
-
Dublin, June 20, 2025 (GLOBE NEWSWIRE) -- The "Neurophotonics Market 2025-2029" report has been added to ResearchAndMarkets.com's offering. The neurophotonics market is projected to expand by USD...
-
EINDHOVEN, the Netherlands, June 17, 2025 (GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD and US OTCQX: ONWRY), the leading neurotechnology company pioneering therapies to restore movement,...
-
Magstim has been granted EU MDR Certification for all transcranial magnetic stimulation (TMS) systems, demonstrating compliance with strict European Union
-
Lakewood, CO, April 09, 2025 (GLOBE NEWSWIRE) -- FOR IMMEDIATE RELEASE KRTL Holding Announces Acquisition of Neurogen Brain Balancing, LLC – A Strategic Merger Accelerating Global Neurotech and...
-
PathMaker Neurosystems Announces Issuance of Three Patents Protecting the Use of Company’s Proprietary Neuromodulation Technology in ALS